Vivos Therapeutics (VVOS) Goodwill & Intangibles (2019 - 2025)
Vivos Therapeutics has reported Goodwill & Intangibles over the past 7 years, most recently at $12.6 million for Q4 2025.
- Quarterly Goodwill & Intangibles rose 294.05% to $12.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.6 million through Dec 2025, up 294.05% year-over-year, with the annual reading at $12.6 million for FY2025, 294.05% up from the prior year.
- Goodwill & Intangibles was $12.6 million for Q4 2025 at Vivos Therapeutics, up from $10.7 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $12.6 million in Q4 2025 and troughed at $3.0 million in Q1 2021.
- The 5-year median for Goodwill & Intangibles is $3.2 million (2024), against an average of $4.4 million.
- Year-over-year, Goodwill & Intangibles fell 2.84% in 2024 and then soared 294.05% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $3.2 million in 2021, then fell by 2.58% to $3.1 million in 2022, then rose by 3.8% to $3.2 million in 2023, then dropped by 0.34% to $3.2 million in 2024, then soared by 294.05% to $12.6 million in 2025.
- Per Business Quant, the three most recent readings for VVOS's Goodwill & Intangibles are $12.6 million (Q4 2025), $10.7 million (Q3 2025), and $10.7 million (Q2 2025).